Daily treatment of mice with type 2 diabetes with adropin for four weeks improves glucolipid profile, reduces hepatic lipid content and restores elevated hepatic enzymes in serum

HIGHLIGHTS

• who: Marek Skrzypski and colleagues from the Department of Animal Physiology, Biochemistry and Biostructure, Poznan University of Life Sciences, Wolynska, Poznan, Poland have published the paper: Daily Treatment of Mice with Type 2 Diabetes with Adropin for Four Weeks Improves Glucolipid Profile, Reduces Hepatic Lipid Content and Restores Elevated Hepatic Enzymes in Serum, in the Journal: (JOURNAL) of 29/08/2022
• what: The aim of this study was to investigate the effects of daily administration of adropin for in mice with experimentally induced type 2 diabetes (T2D). In the present study, weof evaluated on and . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.